The table below shows CUMBERLAND PHARMACEUTICALS INC's income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Revenue
$44.52M
$37.87M
$39.55M
$42.01M
$35.99M
$37.44M
Cost of revenue
$6.67M
$6.59M
$6.07M
$9.12M
$8.81M
$8.65M
Gross profit
-
-
-
-
-
-
R&D
$5.57M
$4.82M
$5.83M
$6.69M
$5.68M
$5.77M
SG&A
CPIX annual revenue (10-K history)
CUMBERLAND PHARMACEUTICALS INC reported annual revenue of $44.52M for fiscal year 2025. That is up 17.6% from $37.87M in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $33.03M (FY 2016) to $44.52M. Figures come from the company's audited annual reports as filed with the SEC.